NASENI Troment Manufacturing Facility
A completed local diagnostic-manufacturing facility integrating PCR-test and lateral-flow rapid-test production capability.
What is publicly disclosed.
A completed local diagnostic-manufacturing facility integrating PCR-test and lateral-flow rapid-test production capability.
The project is classified as PCR and rapid-test manufacturing facility. Its public status is Completed, and the published location is Nigeria. Where the disclosed area is available, it is stated as 2,000 m²; this value is not converted into a cleanroom, operating or ownership claim.
Scope is separated by work package.
- PCR-test production infrastructure
- Rapid-test production infrastructure
- Controlled production workflow
- Equipment integration
- Local workforce and technology-transfer preparation
Each item describes the disclosed engagement boundary. It does not imply services outside the listed scope or transfer responsibility from the client, operator, technology owner or competent authority.
Evidence follows the Seven-Gate Framework.
Reference evidence is assessed against investment definition, concept design, engineering, procurement and technology integration, quality readiness, commissioning and operational handover. The applicable gates depend on the contracted work packages. A design-only engagement is not presented as construction; equipment supply is not presented as complete EPC.
Review the Seven-Gate Framework ↗What this page does not claim.
Capacity, contract value and restricted commercial data remain controlled. No third-party website testimonials or placeholder claims are imported.
Certification, accreditation, product registration and market authorisation remain subject to independent competent authorities and the accountable legal entity. Commercial values, restricted drawings, capacities and client documentation are released only where authorised or during qualified due diligence under NDA.
Connect the reference to an investable project scope.
The reference demonstrates a disclosed technical engagement, not a generic promise of identical cost, capacity or schedule elsewhere. A new programme must be sized for destination-market demand, utilities, workforce, regulatory pathway, site conditions and intended operating model.